Mirapex ER

See also: Generic Mirapex

Mirapex ER is a brand name of pramipexole, approved by the FDA in the following formulation(s):

MIRAPEX ER (pramipexole dihydrochloride - tablet, extended release; oral)

• 
  Manufacturer: BOEHRINGER INGELHEIM
  
  Approval date: February 19, 2010
  
  Strength(s): 0.375MG ^[RLD], 0.75MG, 1.5MG, 3MG, 4.5MG
  


• 
  Manufacturer: BOEHRINGER INGELHEIM
  
  Approval date: June 17, 2011
  
  Strength(s): 2.25MG, 3.75MG
  

Has a generic version of Mirapex ER been approved?

No. There is currently no therapeutically equivalent version of Mirapex ER available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Mirapex ER. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
  Patent 7,695,734
  Issued: April 13, 2010
  Inventor(s): Friedl; Thomas & Eisenreich; Wolfram
  Assignee(s): Boehringer Ingelheim International GmbH
  An extended release tablet formulation comprising pramipexole or a pharmaceutically acceptable salt thereof in a matrix comprising at least one water swelling polymer other than pregelatinized starch.
  
  Patent expiration dates:
  
  
  • April 26, 2028
    
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • February 19, 2013 - NEW DOSAGE FORM
  
  
  • March 19, 2013 - TREATMENT OF SIGNS AND SYMPTOMS OF ADVANCED IDIOPATHIC PARKINSON'S DISEASE
  
  

See also...

• Mirapex ER Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Mirapex ER Consumer Information (Cerner Multum)
• Mirapex ER Advanced Consumer Information (Micromedex)
• Pramipexole Consumer Information (Wolters Kluwer)
• Pramipexole Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Pramipexole Consumer Information (Cerner Multum)
• Pramipexole Advanced Consumer Information (Micromedex)
• Pramipexole Dihydrochloride AHFS DI Monographs (ASHP)